Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.10
Delayed Data
As of Apr 28
 +0.02 / +0.39%
Today’s Change
4.39
Today|||52-Week Range
9.29
-11.61%
Year-to-Date

Today’s Trading

Previous close5.08
Today’s open5.04
Day’s range4.93 - 5.12
Volume1,755,462
Average volume (3 months)2,864,721
Market cap$1.0B
Dividend yield--
Data as of 4:05pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book7.87

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.25+1.81%
ALDRAlder Biopharmaceuti...-1.30-6.09%
CORTCorcept Therapeutics...+0.20+2.14%
FOLDAmicus Therapeutics ...-0.14-1.79%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts